Key result
Robotic pericardial window with tumor biopsy enables diagnosis and prevents effusion recurrence at 6 months.
Case Report (n=1)
Concomitant robotic pericardial window with intraoperative ultrasound-guided biopsy is a viable, minimally invasive approach for diagnosing and managing complex mediastinal masses presenting with pericardial effusion.
Answers are grounded in this paper and cite their sources.
Robotic pericardial window with biopsy may be feasible in select elderly patients with mediastinal mass and effusion; leaves open need for prospective validation.
Herein, we reported the case of an 83-year-old woman with an undiagnosed mediastinal mass and a loculated, symptomatic pericardial effusion, managed by concomitant robotic pericardial window and tumor biopsy under intraoperative ultrasound guidance, with a final diagnosis of B-cell lymphoma. The patient underwent chemo-immunotherapy; at 6-month follow-up, echocardiogram and chest CT showed tumor shrinkage and no effusion recurrence.
No takes yet. Share an insight, caveat, or question.
Fiorelli et al. (2026) conducted a case report in Mediastinal mass and loculated, symptomatic pericardial effusion (n=1). Concomitant robotic pericardial window and tumor biopsy under intraoperative ultrasound guidance was evaluated on Diagnosis, tumor shrinkage, and effusion recurrence. Concomitant robotic pericardial window and tumor biopsy yielded a diagnosis of B-cell lymphoma with subsequent tumor shrinkage and no effusion recurrence at 6 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: